
Oral Cannabidiol Does Not Reduce Acute Non-traumatic Low Back Pain

Oral Cannabidiol Does Not Reduce Acute Non-traumatic Low Back Pain
The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain
Med J Aust. 2021 May;214(8): 370-375.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred patients with acute, non-traumatic low back pain presenting to the emergency department were randomized to receive a single-dose of oral cannabidiol (400mg) or placebo in addition to standard emergency department analgesic medication. The primary outcome of interest was pain score two hours after administration of the study agent on a verbal numerical pain scale. Secondary outcomes inc...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Join the Conversation
Please Login or Join to leave comments.